Home|Journals|Articles by Year|Audio Abstracts

Original Article

Antipromastigote and cytotoxic activities of some chemical constituents of Hypericum lanceolatum Lam. (Guttifereae)

Theodora K. Kowa, Lauve R. Y. Tchokouaha, Jean Noel Nyemb, Hippolyte K. Wabo, Alembert T. Tchinda, Regina Appiah-Opong, Gabriel A. Agbor, Pierre Tane, Michel Frederich.


Phytochemical investigation of the ethanol extract of the stem bark of Hypericum lanceolatum Lam. (Guttifereae) afforded eight known compounds including 2,2',5,6'-tetrahydroxybenzophenone (1), 5-hydroxy-3-methoxyxanthone (2), 3-hydroxy-5-methoxyxanthone (3), betulinic acid (4), hydroquinone (5) 6,7-dihydroxy-1,3-dimethoxyxanthone (6), calophyllumin A (7) and 1,3,5,6-tetrahydroxy-4-prenylxanthone (8). Compound 1 was submitted to acetylation reaction to give 5-acetoxy-2,2',6'-trihydroxybenzophenone (9), a new hemisynthetic derivative. Compounds 5 and 8 were isolated for the first time from this plant. The structures were established by extensive analysis of their MS and NMR spectroscopic data and comparison with those from the literature. The isolated compounds (1, 2, 4, 5, and 8) and derivative of benzophenone (9) were tested for their antipromastigote and cytotoxic activities against visceral leishmaniasis parasite Leishmania donovani and macrophage RAW 264.7 cell line, respectively. Compound 9 was the most active with IC50 value of 6.1 µg/mL, while compounds 1, 2, 4 and 8 were moderately active with IC50 values ranging from 11.4 to 34.8 µg/mL against L. donovani and were not cytotoxic except compound 5 which was very toxic and not active. The findings of the present study suggested that compounds 1, 2, 4, and 8 could be considered as a potential source of therapeutic medicine for the treatement of leishmaniasis.

Key words: Guttiferae; Hypericum lanceolatum; benzophenone; antipromastigote activity; cytotoxicity.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.